Essential HL Random Thoughts Thread

DEAD7

Veteran
Supporter
Joined
Oct 5, 2012
Messages
50,878
Reputation
4,381
Daps
88,942
Reppin
Fresno, CA.
You should see some of things the founders of the American republic and it's economic system thought and did. Those are real doozies. Heard some of them even owned slaves.:whoo:
:hubie:
Just showing you didn’t/don’t have to be capitalist as is oft suggested to hate and shyt on blacks.
:hubie:
Economics don’t matter when it comes to hate.
 

Pressure

#PanthersPosse
Supporter
Joined
Nov 19, 2016
Messages
45,793
Reputation
6,890
Daps
145,973
Reppin
CookoutGang
HL Dems must be waiting for the spin before they post a thread on the unemployment rate drop and the fewest number of people receiving unemployment since 1973...
:lolbron:
You clearly didn't read the jobs report.

The number dropped because people left the work force and not a result of job creation and/or a higher number of employed workers.

Troll better. :mjgrin:
 

Shogun

Veteran
Joined
May 3, 2012
Messages
25,489
Reputation
5,926
Daps
62,971
Reppin
Knicks
Libertarians should read Timothy Snyder's Bloodlands, or listen to one of his lectures:



Basic thesis is that tyranny results from the breakdown of government institutions. His particular point is that the Holocaust happened not in Germany, but outside of Germany where the state was destroyed. Also, the only people who could really save people from the Nazi's were bureaucrats.

His newer book focuses more heavily on how institutions protect us, and that thinking we dont need them is a fantasy.
 
Joined
Sep 15, 2015
Messages
21,780
Reputation
7,351
Daps
92,268
Reppin
Chase U
No thread here on the effort to lower cost of prescription drugs?

Why not make one? Anyway, early reporting indicates that the plan does not do much to curb the high cost of prescription drugs - it actually helps big pharma.

Drug Industry Dodges Its Worst Fears in Trump’s Plan to Lower Prices



President Donald Trump’s plan to lower U.S. drug prices avoids some of the harshest steps that the pharmaceutical industry and the network of companies that distribute its products feared.

Calling his proposal the most sweeping attempt in U.S. history to lower drug prices, Trump wants to increase competition for medicines, cut list prices and reduce patients’ out-of-pocket costs. Yet it also preserves -- and in some cases expands -- the role of the pharmacy middlemen the administration has blamed for many problems with drug costs.

“We’ll have much lower prices at the pharmacy counter and it’ll start taking effect immediately,” Trump said in a speech in the White House Rose Garden on Friday. “We’re also increasing competition and reducing regulatory burdens so drugs can be gotten to the market quicker and cheaper.”

Few of the steps proposed by the administration would take immediate effect. The 44-page document is laid out as topics for discussion and contains more than 100 questions about what the administration should do. Industry stocks gained after the speech.

“It’s going to be months for the kind of actions that we need to take here,”s aid Health and Human Services Secretary Alex Azar, Trump’s top health official. “It took decades to erect this very complex, interwoven system. I don’t want to over-promise that somehow on Monday there’s radical changes. There’s a deep commitment.”


Nowhere in the proposal does the administration call for two policies the industry most feared: having the government directly negotiate prices and allowing the importation of prescription drugs from overseas. Trump had previously backed both of those ideas, promising to use the government’s buying power to get better deals.

In the months ahead of the speech, drug companies and pharmacy benefit managers, or PBMs, have traded accusations over who’s to blame for high U.S. drug costs. In the immediate aftermath, company stocks in both industries were up -- a sign that investors think that the worst-case scenario has been avoided, for now.

“The speech was very Trump; it was bombastic, and he made his points,” said Spencer Perlman, an industry analyst with Veda Partners. “But we will have to find out what ideas are real and how they can implement them. If you’re investing for the next six months, today’s a good day for you.”

The Nasdaq Biotechnology Index rose 2.7 percent, the biggest gain in four weeks. The 193-company index is a barometer of investor sentiment about the drug industry and pricing issues.




 
Top